哪吒机器人提醒：
提醒：Biotech Sector and Stocks Analysis from Seeking Alpha
【标题】Vertex Pharmaceuticals: Telaprevir a Likely Lock for Approval
【摘要】bert wilkison submits:on 04/07/11, vertex pharmaceuticals (vrtx) made headlines when it announced that one of its long time collaborators, cystic fibrosis foundation therapeutics, agreed to provide up to $75m over the next five years to support research and development for some of vertex's early stage product candidates in exchange for entitlement to royalties on future sales. more importantly, the company has a food and drug administration [fda] advisory committee [adcom] meeting scheduled for ... (04-19 23:00)
手机哪吒网 m.iNezha.com 有人网